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The promotion of exercise as a positive and powerful health intervention has never been 
more important, when consideration is given to 
the global epidemic of disease states related to a 
sedentary lifestyle. However, intensive exercise may 
be a trigger for sudden cardiac death in individuals 
harbouring quiescent cardiovascular diseases. 
Indeed, hereditary and congenital abnormalities 
of the heart are the most common cause of non-
traumatic death during sport in young athletes.1 
The incidence of sudden cardiac death in young 
athletes (<35 years) is estimated at 1:50,000.2 
The most common cause of death in young 
athletes worldwide is hypertrophic cardiomyopathy, 
which is implicated in over one third of all sudden 
cardiac deaths in young American athletes.1 
Arrhythmogenic right ventricular cardiomyopathy 
is the most common cause of death in Italy.3 Data 
from a specialist cardiology pathology centre in 
the UK have shown that in up to 40% of cases, 
the heart is structurally normal. In many, such 
cases are often attributed to primary cardiac ion-
channel disorders such as the long QT syndrome, 
Brugada syndrome, catecholaminergic polymorphic 
ventricular tachycardia, or congenital electrical 
accessory pathways.4 Almost 90% of deaths 
occur in males, and 40% of athletes are aged <18 
years old.1 Data from the USA suggest that black 
athletes, and those participating in explosive sport 
of start-stop nature, such as football and basketball, 
may be more prone to sudden cardiac death.5,6 
Although the incidence of sudden cardiac death 
during sport is relatively low, such events are 
magnified by the media and have a huge impact on 
society as a whole. Identification of athletes at risk 
of sudden cardiac death has become an important 
focus of the medical community, on the premise 
that the majority of implicated diseases can be 
detected during life, and acceptable interventions, 
such as lifestyle modification, pharmacological 
therapy, radiofrequency ablation of accessory 
pathways or implantation of a cardioverter 
defibrillator, are available to reduce the risk of 
sudden cardiac death. Screening young athletes 
with electrocardiogram (ECG) is effective for 
detecting individuals with Wolff-Parkinson-White 
ECG pattern, the long QT syndrome and a large 
percentage of cardiomyopathies. Whether detection 
of disease equates to lives saved is a contentious 
issue. The most persuasive evidence supporting 
that early detection of disease saves lives is derived 
from a large prospective Italian study, which 
reported an 89% reduction in sudden cardiac 
death in athletes screened with ECG over a 25-
year period.7 Despite the findings from this study, 
there is antagonism from some to implementing 
such policies in the UK. Concerns relate to a high 
number of false-positive results, and consequent 
cost implications. 
Intensive exercise training is associated with 
a constellation of physiological alterations in 
autonomic tone, cardiac structure and cardiac 
function, which may be reflected as electrical 
anomalies on the ECG.8 These electrical 
expressions of the athlete’s heart can overlap with 
those observed in patients with cardiomyopathy, 
particularly in black athletes and in athletes 
participating in endurance sport.9-14 
The 2010 European Society of Cardiology 
(ESC) recommendations for ECG interpretation 
in athletes are associated with a false-positive 
rate ranging from 9% to 22%.10,15,16 The more 
contemporary Seattle criteria and refined criteria 
for ECG interpretation in athletes have significantly 
improved specificity for detecting cardiac disease 
without compromising sensitivity.10,16,17 Whether 
modification of ECG interpretation criteria is 
associated with a significant cost reduction had 
never been investigated. 
UK situation
The UK does not support a state-sponsored 
screening programme in athletes. Cardiovascular 
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evaluation is usually reserved for young 
individuals with symptoms suggestive of 
cardiac disease, an abnormal physical 
examination or a family history of premature 
or inherited cardiac disease. However, the 
charitable organisation Cardiac Risk in the 
Young (www.c-r-y.org.uk) has an established 
cardiac screening programme for young 
individuals that also serves many professional 
sporting organisations in the UK.
In the August edition of the Journal of 
the American College of Cardiology, we 
took advantage of these screening data 
to report the cost implications of athletes 
being screened for cardiac disease for the 
first time.18 Initial screening with health 
questionnaire, physical examination and 
ECG was performed at a subsidised cost of 
$53 per athlete. Based on these preliminary 
findings, cardiologists requested secondary 
investigations (if applicable) to confirm 
or refute the presence of cardiac disease, 
the costs of which were calculated based 
on NHS tariffs in the UK. We started with 
calculating the costs pertaining to the number 
of abnormal ECGs and cost of secondary 
investigations based on the original 2010 ESC 
recommendations, and applied the potential 
costs of using the Seattle and refined criteria 
retrospectively. 
Between 2011 and 2014, 4,925 previously 
unscreened athletes aged 14–35 years 
were prospectively evaluated by Cardiac 
Risk in the Young. Only 79 athletes (1.6%) 
required investigations for symptoms, family 
history or abnormal physical examination. 
An abnormal ECG, based on the 2010 ESC 
recommendations, was revealed in 1,072 
(21.8%) athletes. Of these, 11.2% athletes 
required echocardiography, 1.7% exercise 
stress test, 1.2% Holter, 1.2% cardiac 
magnetic resonance imaging (MRI) and 
0.4% other tests. There were 15 (0.3%) 
asymptomatic athletes diagnosed with 
potentially serious cardiac disease following 
investigation of an ECG classified as abnormal 
by all three ECG criteria. The overall cost of 
a de-novo screening programme using the 
2010 ESC recommendations amounted to 
$539,888, equating to $110 per athlete and 
$35,993 per serious diagnosis.
The Seattle and refined criteria reduced 
the number of positive ECGs to 6.0% and 
4.3%, respectively, and resulted in a relative 
reduction in the number of athletes requiring 
further investigation following screening by 
more than 50%. Specifically, the refined 
criteria would have resulted in a 50% 
reduction in the number of echocardiograms, 
12% reduction in the number of exercise 
tests, 8% reduction in Holter monitors, and 
18% reduction in the number of cardiac MRI 
scans that would need to be performed to 
confirm (or refute) the diagnosis of cardiac 
disease. 
As a consequence of the reduction in 
downstream investigations, the Seattle and 
refined criteria reduced the cost to $92 and 
$87 per athlete screened and $30,251 and 
$28,510 per serious diagnosis, respectively, 
representing an impressive 21% cost saving, 
without compromising the sensitivity to detect 
serious cardiac disease (figure 1).
These results represent a welcome saving 
for sporting organisations equipped with 
the infrastructure and expertise for cardiac 
screening in athletes, and may also 
enable less financially endowed sporting 
organisations to afford screening for their 
athletes. There are persuasive arguments 
that such financial resources would be better 
served in establishing cardiopulmonary 
resuscitation facilities, which have proven 
effective in reducing the incidence of death 
after sudden cardiac arrest.19-21 However, 
one must consider that 40% of deaths in 
athletes occur at rest in their homes, where 
early access to defibrillation is unlikely, 
and, therefore, early identification of at-risk 
individuals through screening is an important 
preventative strategy.4 
This is the most comprehensive assessment 
of direct cost associated with cardiovascular 
screening of young athletes, and the first 
study involving British athletes. The study 
highlights pertinent financial issues in relation 
to ECG screening in young athletes and 
provides a wider perspective to the ongoing 
debate relating to best practice in identifying 
young individuals at risk of sudden cardiac 
death • 
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Figure 1. Implications of contemporary electrocardiogram (ECG) interpretation criteria on pre-
participation screening, workload of secondary investigation and cost
Contemporary 
ECG interpretation 
guidelines
>80% relative 
↓ in abnormal 
ECGs
21% reduction 
in cost
Maintain 
sensitivity to 
detect athletes 
at risk of SCD
↓ Echo 50% 
↓ EST 12% 
↓ Holter 8% 
↓ CMR 18%
Key: CMR = cardiac magnetic resonance imaging; EST = exercise stress test; SCD = sudden cardiac death
